Daiichi Sankyo Co., Ltd. is a global pharmaceutical company known for its research and development in the fields of oncology, cardiovascular diseases, and vaccines. Founded in 2005 through a merger, the company focuses on advancing medical care worldwide.
Daiichi Sankyo develops and manufactures drugs for various therapeutic areas, including oncology and cardiovascular health.
The company has committed to sustainability through reducing environmental impacts, improving access to healthcare, and supporting global health initiatives.
Daiichi Sankyo operates in over 20 countries, with a strong presence in Japan, the U.S., and Europe, among others.
Further Details
Some additional details about the company are listed below:
| Parameter | Details |
|---|---|
| Daiichi Sankyo Co., Ltd. | http://www.daiichisankyo.com |
| Company Name | Daiichi Sankyo Co., Ltd. |
| Core Focus | Development of innovative medicines for unmet medical needs |
| Sustainability Recognition | Environmental responsibility and access to medicines |
| Key Technologies | Drug discovery, biologics, small molecules |
| Solutions Offered | Oncology, cardiovascular, and metabolic disorder therapies |
| Application Areas | Healthcare, oncology, cardiovascular care |
| Industry | Pharmaceuticals |
FAQs
Daiichi Sankyo specializes in oncology, cardiovascular, and metabolic disorder treatments.
The company develops biologics, small molecules, and therapies for cancer, heart disease, and metabolic disorders.
Daiichi Sankyo is based in Tokyo, Japan.
Daiichi Sankyo utilizes drug discovery, biologics, and small molecule technologies.
The company focuses on environmental responsibility and ensuring access to essential medicines.